Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
The current price of Moderna Inc in the market is 218,07 zł, with a 24-hour trading volume of 865,77K zł. The asset's market cap is 86,53B zł, after moving 0.82% in the last day.
Tokenized Moderna Inc is trading at 216,74 zł, with a tokenized market cap of 223,03K zł and a 24-hour trading volume of 2,28M zł. The tokenized asset has moved -1.03% in the past 24 hours.